A humanized mouse model of HPV-associated pathology driven by E7 expression

A humanized mouse model of HPV-associated pathology driven by E7 expression

Human papillomavirus (HPV) is the causative agent of human cervical cancer and has been associated with oropharyngeal squamous cell carcinoma development. Although prophylactic vaccines have been developed, there is a need to develop new targeted therapies for individuals affected with malignant inf...

Full description

Bibliographic Details
Main Authors:	Buitrago-Pérez, Á, Hachimi, M, Dueñas, M, Lloveras, B, Santos, A, Holguín, A, Duarte, B, Santiago, J, Akgül, B, Rodríguez-Peralto, J, Storey, A, Ribas, C, Larcher, F, Del Rio, M, Paramio, J, García-Escudero, R
Format:	Journal article
Language:	English
Published:	Public Library of Science 2012

Similar Items

A humanized mouse model of HPV-associated pathology driven by E7 expression.
by: Águeda Buitrago-Pérez, et al.
Published: (2012-01-01)

Pathological variants in HPV-independent vulvar tumours
by: Sanja A. Farkas, et al.
Published: (2025-01-01)

Evaluation of comprehensive treatment of cervical pathology associated with HPV
by: T Yu Pestrikova, et al.
Published: (2015-08-01)

Identification of the regions of the HPV 5 E6 protein involved in Bak degradation and inhibition of apoptosis.
by: Simmonds, M, et al.
Published: (2008)

Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
by: Ian N. Hampson
Published: (2022-04-01)

HPV vaccination of immunocompromised hosts
by: S.M. Garland, et al.
Published: (2017-12-01)

Therapeutic possibilities in treatment of cervical pathology in patients with HPV-infection
by: E A Chulkova, et al.
Published: (2015-04-01)

Update on Effects of the Prophylactic HPV Vaccines on HPV Type Prevalence and Cervical Pathology
by: Ian N. Hampson, et al.
Published: (2024-08-01)

Correction: HPV Testing by cobas HPV Test in a Population from Catalonia.
by: Belén Lloveras, et al.
Published: (2013-01-01)

Microbiome factors in HPV-driven carcinogenesis and cancers.
by: Daniel Lin, et al.
Published: (2020-06-01)

High prevalence of HPV 18 and multiple infections with oncogenic HPV genotypes in women at risk of cervical cancer examined in Manaus, Brazil
by: C. Fantin, et al.
Published: (2023-05-01)

Accuracy of high-risk HPV DNA PCR, p16(INK4a) immunohistochemistry or the combination of both to diagnose HPV-driven oropharyngeal cancer
by: Cindy Simoens, et al.
Published: (2022-08-01)

Hpv-Specific Risk Management in Cervical Pathology Screening and Comparison of Pathological Results
by: Ali Acar, et al.
Published: (2023-12-01)

Approaching a decade since HPV vaccine licensure: Racial and gender disparities in knowledge and awareness of HPV and HPV vaccine
by: Eric Adjei Boakye, et al.
Published: (2017-11-01)

The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study
by: Claire Bavor, et al.
Published: (2023-10-01)

Focus on HPV‑driven head and neck cancers
by: Luisa Lina Villa, et al.
Published: (2022-01-01)

WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58
by: Troy J. Kemp, et al.
Published: (2024-09-01)

CD44v6, STn & O-GD2: promising tumor associated antigens paving the way for new targeted cancer therapies
by: Iris Lodewijk, et al.
Published: (2023-10-01)

Ten years of HPV vaccination in the Netherlands: current evidence and future challenges in HPV-related disease prevention
by: V. Qendri, et al.
Published: (2018-12-01)

Screening of 100 women for HPV infection and HPV genotyping
by: M. Jamshidi Makiani, et al.
Published: (2014-04-01)

The E2 protein of human papillomavirus type 8 increases the expression of matrix metalloproteinase-9 in human keratinocytes and organotypic skin cultures.
by: Akgül, B, et al.
Published: (2011)

Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.
by: Audrey J King, et al.
Published: (2016-01-01)

T-cell receptor determinants of response to chemoradiation in locally-advanced HPV16-driven malignancies
by: Pablo Nenclares, et al.
Published: (2024-01-01)

Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies
by: Bedia Dinc, et al.
Published: (2010-01-01)

Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies
by: Bedia Dinc, et al.

Cutaneous Human Papillomavirus E7 Type-Specific Effects on Differentiation and Proliferation of Organotypic Skin Cultures
by: K. Westphal, et al.
Published: (2009-01-01)

The prevalence of human papillomavirus genotypes (HPV-6, HPV-11, HPV-16, and HPV-18) in the unilateral and bilateral nasal polyps
by: Amani M Abd Elwahab, et al.
Published: (2017-01-01)

Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the Netherlands.
by: Audrey J King, et al.
Published: (2016-01-01)

Advanced Nanomedicine for High-Risk HPV-Driven Head and Neck Cancer
by: Qiang Xu, et al.
Published: (2022-12-01)

Cutaneous HPV5 E6 causes increased expression of Osteoprotegerin and Interleukin 6 which contribute to evasion of UV-induced apoptosis.
by: Tomlins, C, et al.
Published: (2010)

Medical students’ knowledge of HPV, HPV vaccine, and HPV-associated head and neck cancer
by: Eric Y. Du, et al.
Published: (2022-11-01)

Analysis of E2 gene integrity in HPV16 and HPV58 viruses isolated from women with cervical pathology
by: María del R González-Losa, et al.

HPV genotype-specific concordance between EuroArray HPV, Anyplex II HPV28 and Linear Array HPV Genotyping test in Australian cervical samples
by: Alyssa M. Cornall, et al.
Published: (2017-12-01)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
by: Carmen Radecki Breitkopf, et al.
Published: (2016-11-01)

Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy
by: Buitrago-Pérez Águeda, et al.
Published: (2010-07-01)

PCR-RFLP assay as an option for primary HPV test
by: L. Golfetto, et al.
Published: (2018-03-01)

Oxidative stress in HPV-driven viral carcinogenesis: redox proteomics analysis of HPV-16 dysplastic and neoplastic tissues.
by: Federico De Marco, et al.
Published: (2012-01-01)

HPV vaccination practices among organ transplant recipients in France
by: J. de Quatrebarbes, et al.
Published: (2024-01-01)

Correcting HPV Vaccination Misinformation Online: Evaluating the <i>HPV Vaccination NOW</i> Social Media Campaign
by: Beth Sundstrom, et al.
Published: (2021-04-01)

Human papillomavirus (HPV) genotype distribution in penile carcinoma: Association with clinic pathological factors.
by: Lyriane Apolinário de Araújo, et al.
Published: (2018-01-01)